TABLE 1 OTHER CLINICAL TRIALS
TABLE 2 WORLD RENAL DENERVATION MARKET, BY TYPE, 20142022 ($MILLION)
TABLE 3 SYMPLICITY RENAL DENERVATION SYSTEM MARKET, BY REGION, 20142022 ($MILLION)
TABLE 4 VESSIX RENAL DENERVATION SYSTEM MARKET, BY REGION, 20142022 ($MILLION)
TABLE 5 ENLIGHTN RENAL DENERVATION SYSTEM MARKET, BY REGION, 20142022 ($MILLION)
TABLE 6 PARADISE RENAL DENERVATION SYSTEM MARKET, BY REGION, 20142022 ($MILLION)
TABLE 7 IBERIS RENAL DENERVATION SYSTEM MARKET, BY REGION, 20142022 ($MILLION)
TABLE 8 OTHER RENAL DENERVATION SYSTEMS MARKET, BY REGION, 20142022 ($MILLION)
TABLE 9 WORLD RENAL DENERVATION MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 10 RADIOFREQUENCY RENAL DENERVATION MARKET, BY REGION, 20142022 ($MILLION)
TABLE 11 ULTRASOUND RENAL DENERVATION MARKET, BY REGION, 20142022 ($MILLION)
TABLE 12 MICRO-INFUSION RENAL DENERVATION MARKET, BY REGION, 20142022 ($MILLION)
TABLE 13 RENAL DENERVATION MARKET, BY GEOGRAPHY, 20142022 ($MILLION)
TABLE 14 NORTH AMERICA: RENAL DENERVATION MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 15 NORTH AMERICA: RENAL DENERVATION MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 16 NORTH AMERICA: RENAL DENERVATION MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 17 EUROPE: RENAL DENERVATION MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 18 EUROPE: RENAL DENERVATION MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 19 EUROPE: RENAL DENERVATION MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 20 ASIA-PACIFIC: RENAL DENERVATION MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 21 ASIA-PACIFIC: RENAL DENERVATION MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 22 ASIA-PACIFIC: RENAL DENERVATION MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 23 LAMEA: RENAL DENERVATION MARKET, BY COUNTRY, 20142022 ($MILLION)
TABLE 24 LAMEA: RENAL DENERVATION MARKET, BY PRODUCT, 20142022 ($MILLION)
TABLE 25 LAMEA: RENAL DENERVATION MARKET, BY TECHNOLOGY, 20142022 ($MILLION)
TABLE 26 ABLATIVE SOLUTIONS: COMPANY SNAPSHOT
TABLE 27 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 28 BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 29 CARDIOSONIC: COMPANY SNAPSHOT
TABLE 30 KONA MEDICAL: COMPANY SNAPSHOT
TABLE 31 MEDTRONIC: COMPANY SNAPSHOT
TABLE 32 MEDTRONIC: OPERATING SEGMENTS
TABLE 33 MERCATOR: COMPANY SNAPSHOT
TABLE 34 RECOR MEDICAL: COMPANY SNAPSHOT
TABLE 35 RENAL DYNAMICS - COMPANY SNAPSHOT
TABLE 36 ST. JUDE MEDICAL: COMPANY SNAPSHOT
TABLE 37 ST. JUDE MEDICAL: PRODUCT CATEGORIES
TABLE 38 TERUMO: COMPANY SNAPSHOT
TABLE 39 TERUMO: OPERATING SEGMENTS

LIST OF FIGURE

FIG. 1 WORLD RENAL DENERVATION MARKET, BY PRODUCT, 2015 VS 2022, ($MILLION)
FIG. 2 RENAL DENERVATION MARKET SEGMENTATION
FIG. 3 TOP INVESTMENT POCKETS IN THE WORLD RENAL DENERVATION MARKET
FIG. 4 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, (20142016)
FIG. 5 TOP WINNING STRATEGIES: NATURE AND TYPE
FIG. 6 TOP COMPANIES AND THEIR STRATEGIES
FIG. 7 DETAILED STRUCTURE OF COMPANIES AND NATURE OF STRATEGIES
FIG. 8 DETAILED STRUCTURE OF COMPANIES AND TYPE OF STRATEGIES
FIG. 9 PORTERS FIVE FORCES ANALYSIS
FIG. 10 MARKET SHARE ANALYSIS, 2015
FIG. 11 TOP IMPACTING FACTORS: RENAL DENERVATION MARKET
FIG. 12 MAIN FACTORS THAT CONTRIBUTE TO THE DEVELOPMENT OF HIGH BLOOD PRESSURE AND ITS COMPLICATIONS
FIG. 13 HYPERTENSION CONTROL IN PATIENTS TREATED BY MULTIDRUG APPROACH, (% OF PATIENTS)
FIG. 14 WORLDWIDE HYPERTENSION POPULATION
FIG. 15 MAJOR CLINICAL TRIALS IN RENAL DENERVATION MARKET
FIG. 16 EUROPE CLINICAL TRIALS, (%)
FIG. 17 ASIA-PACIFIC CLINICAL TRIALS, (%)
FIG. 18 NORTH AMERICA CLINICAL TRIALS, (%)
FIG. 19 LAMEA CLINICAL TRIALS, (%)
FIG. 20 PIPELINE PRODUCTS IN RENAL DENERVATION MARKET
FIG. 21 PREVALENCE OF RESISTANT HYPERTENSION IN NORTH AMERICA (%)
FIG. 22 U.S.: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 23 CANADA: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 24 MEXICO: COSMETIC IMPLANTS MARKET, 20142022 ($MILLION)
FIG. 25 PREVALENCE OF RESISTANT HYPERTENSION IN EUROPE (%)
FIG. 26 GERMANY: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 27 FRANCE: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 28 UK: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 29 ITALY: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 30 SPAIN: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 31 REST OF EUROPE: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 32 PREVALENCE OF RESISTANT HYPERTENSION IN ASIA-PACIFIC (%)
FIG. 33 JAPAN: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 34 CHINA: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 35 INDIA: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 36 AUSTRALIA: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 37 NEW ZEALAND: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 38 OTHERS ASIA-PACIFIC: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 39 PREVALENCE OF RESISTANT HYPERTENSION IN LAMEA (%)
FIG. 40 BRAZIL: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 41 SOUTH AFRICA: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 42 SAUDI ARABIA: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 43 REST OF LAMEA: RENAL DENERVATION MARKET, 20142022 ($MILLION)
FIG. 44 BOSTON SCIENTIFIC: NET SALES, 20132015 ($MILLION)
FIG. 45 BOSTON SCIENTIFIC: NET SALES, BY SEGMENT, 2015 (%)
FIG. 46 BOSTON SCIENTIFIC: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 47 MEDTRONIC: NET SALES, 20142016 ($MILLION)
FIG. 48 MEDTRONIC: NET SALES, BY SEGMENT, 2016 (%)
FIG. 49 MEDTRONIC: NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 50 MEDTRONIC: STRATEGY SHARE, 20132014 (%)
FIG. 51 ST. JUDE MEDICAL: NET SALES, 20132015 ($MILLION)
FIG. 52 ST. JUDE MEDICAL: NET SALES, BY PRINCIPLE PRODUCT CATEGORY, 2015 (%)
FIG. 53 ST. JUDE MEDICAL: NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 54 TERUMO: NET SALES, 20142016 ($MILLION)
FIG. 55 TERUMO: NET SALES, BY SEGMENT, 2016 (%)
FIG. 56 TERUMO: NET SALES, BY GEOGRAPHY, 2016 (%)